ICDM 2025

Committee for patient advocacy (K) Diabetes stigma
(당뇨병 낙인 - 편견을 넘어 공감으로) Chair(s): sunkyung song, Heung Yong Jin
Thursday 25 September, 15:00~16:20
Room 4
(Walker hall 2, 1F)

Diabetes is a chronic condition that requires more than medical treatment-it calls for the support of families and communities. Diabetes stigma refers to the unjust social bias and discrimination faced by people with diabetes, which can harm mental health and reduce treatment adherence. To overcome this, accurate education and empathy-based public awareness are essential. This session, organized by the Committee of Patient Advocacy, will examine the concept and current state of diabetes stigma, present real-world cases from clinical settings, and share practical strategies for stigma reduction. It will also explore directions for future policy and societal change to better protect the rights of people with diabetes. By bringing together people with diabetes, their families, and healthcare professionals, the session aims to deepen empathy and inspire meaningful action.
당뇨병은 단순한 의학적 관리만으로는 충분하지 않은 만성질환으로, 당뇨인과 가족, 지역사회의 협력이 필요하다. ‘당뇨병 낙인’은 당뇨인이 겪는 부당한 사회적 편견과 차별을 의미하며, 정신 건강과 치료 참여에 부정적인 영향을 미친다. 이를 해소하기 위해서는 정확한 정보 제공과 공감 중심의 인식 개선이 중요하다. 이번 환자관리위원회 세션에서는 당뇨병 낙인의 개념과 실태, 실제 진료현장의 사례, 그리고 낙인 완화를 위한 실천 전략을 소개하고, 당뇨인의 권익 보호를 위한 정책적‧사회적 변화 방향을 논의할 예정이다. 당뇨인, 가족, 전문가가 함께하는 이 자리가 공감을 넓히고 실질적인 변화를 이끄는 계기가 되기를 기대한다.

CS01-L1 Su jin JeongBuchecon Sejong Hospital, Korea: Embracing diabetes mellitus within diversity
(다양성 속의 당뇨병을 포용하다)

CS01-L2 Yeon Hee LeeGwangmyeong Sungae Hospital, Korea: Diabetes, a close yet distant companion
(당뇨병, 가깝지만 먼 동반자)

CS01-L3 Sangmin AnSeverance Hospital, Medical Social Work Team, Korea: Let’s team up (우리 함께 합시다!)

Panel discussion

CS01-P1
Hyejeong ChoiNational Evidecne-based Healthcare Collaborating Agency (NECA), Korea
CS01-P2
Binyoung ChaeGQRI, Korea
CS01-P3
Moon-A ChoSeosan Medical Center, Korea

Committee for social contribution (K) Improving accessibility to health care for vulnerable populations with diabetes /
/ (당뇨병 취약층의 건강관리 접근성 향상) Chair(s): Seok O Park, Gyong Ae Choi
Thursday 25 September, 16:30~17:50
Room 4
(Walker hall 2, 1F)

The Social Contribution Committee has organized this session to highlight the healthcare challenges faced by vulnerable populations excluded from adequate diabetes management due to socio-economic barriers. The session will examine disparities in diabetes care among low-income groups and introduce current community support systems, including public initiatives and public-private partnerships. It will also explore strategies to connect and leverage private sector resources to build sustainable care models. By fostering collaboration across healthcare, welfare, and non-profit sectors, this session aims to identify practical solutions and share insights to improve the quality of life for underserved individuals living with diabetes.
사회공헌위원회는 사회·경제적 제약으로 적절한 당뇨병 관리를 받지 못하는 취약계층의 건강 현실을 조명하고, 의료 접근성을 높이기 위한 다양한 전략을 모색하고자 이번 세션을 마련하였다. 특히 저소득층을 중심으로 한 당뇨병 관리의 사각지대를 살펴보고, 지역사회 내 공공기관 및 민관협력 기반의 지원체계를 소개하며, 민간 자원의 연계 및 활용 방안을 제안한다. 보건의료, 복지, 비영리 분야 간의 실질적 협력 가능성을 모색하는 이번 자리는 다학제 전문가들이 함께 모여 실질적인 해법을 논의하고, 당뇨병 취약계층의 삶의 질 향상을 위한 지혜를 나누는 뜻깊은 자리가 될 것이다.

CS02-L1 Soo MI JangCheongju University, Department of Social Welfare, Korea: Diabetes self-management in a low-income population: implications for interventions and social policies
(취약계층의 당뇨병 자기관리와 사회적 지지방안)

CS02-L2 Jisun ChoiKorea Human Resource Development Institute for Health and Welfare, Korea: Understanding community-based case management for diabetes patients with complex needs
(복합적 욕구가 있는 당뇨병 환자에 대한 지역사회 사례관리는 어떻게 이루어지는가?)

CS02-L3 Suhyeon LeeCommunity Chest of Korea, Korea: Donation environment, donation ecosystem, non-profit organizations
(기부환경, 기부생태계, 비영리조직)

Panel discussion

CS02-P1
Hyangsoo KimSungkonghoe University, Institute for Gender Studies, Korea
CS02-P2
Yujeong ParkAnsan University, Department of Social Welfare, Korea

Committee of clinical practice guideline session (K) KDA consensus statement unpacked: practical strategies for optimizing glycemic care in type 2 diabetes Chair(s): Sin Gon Kim, Byung-Wan Lee
Friday 26 September, 15:00~16:20
Room 2
(Vista 3, B2F)

This session will highlight key issues from the upcoming 2025 KDA Consensus Statement on Screening and Pharmacotherapy in Type 2 Diabetes. While the 9th edition of the KDA guidelines emphasizes evidence-based care, this new statement also reflects expert consensus where high-level evidence is lacking. It aims to offer practical, real-world guidance to better support clinical decision-making in diabetes management.

CS05-L1 Won Jun KimUniversity of Ulsan, Korea: Bridging evidence and practice: real-world consensus on diabetes screening in Korean patients

CS05-L2 Shinae KangYousei University, Korea: Advancing pharmacologic therapy: practical and personalized algorithms for type 2 diabetes in Korea

CS05-L3 Jaehyun BaeHallym University, Korea: Breaking barriers in oral combination therapy: real-world, evidence-based recommendations for Korean patients
(한국인 당뇨병 환자를 위한 경구혈당강하제 병용요법)

CS05-L4 Jonghan ChoiKonkuk University, Korea: Optimizing injectable therapies: practical approaches including incretin-based drugs for Korean patients

Young-onset diabetes & diabetes in pregnancy TFT Global alliance to stop young-onset diabetes Chair(s): Yeon Ah Sung, Soo Heon Kwak
Friday 26 September, 16:30-17:50
Room 2
(Vista 3, B2F)

This session addresses the rising global challenge of young-onset type 2 diabetes, with insights into its epidemiology, genetic underpinnings, and clinical characteristics across diverse populations. Experts will present emerging evidence from global and East Asian cohorts, and explore innovative strategies for prevention and management. The session highlights the urgent need for international collaboration and tailored interventions to curb the early-life burden of diabetes.

CS03-L1 Shivani MisraImperial College London, UK: Current insights and emerging trends in early-onset type 2 diabetes

CS03-L2 Shylaya SrinivasanUniversity of California, USA: Genetic characteristics of youth-onset type 2 diabetes

CS03-L3 Nam Hoon KimKorea University, Korea: Clinical features and implications of early-onset type 2 diabetes in East Asians

CS03-L4 Jin Hwa KimChosun University, Korea: Innovative strategies for prevention and management of young-onset diabetes

Diabetic policy forum session (K) Issues around the use of incretin-based antidiabetic medication in Korea
(우리나라에서의 인크레틴-기반 당뇨병약의 사용, 이대로 괜찮은가) Chair(s): Dae Jung Kim, Soo-Kyung Kim
Friday 26 September, 16:30-17:50
Room 4
(Walker hall 2, 1F)

This session will highlight and discussion issues around the use of incretin-based antidiabetic medication in Korea. This session will present the history, current status and future of GLP-1 receptor agonists Also, this session will present the effectiveness, current approval state and barriers of the new incretin-based drugs in Korea. It aims to support that incretin-based medications can be provided and prescribed appropriately in Korea.
본 세션에서는 먼저 GLP-1 수용체 작용제의 과거와 현재, 미래, 그리고 국내에서 새로 도입될 인크레틴 기반한 약제들의 효과, 현재 우리나라의 허가 단계, 장벽과 오남용 우려 등에 대한 이슈를 다루고자 한다. 이를 통해 국내에서 인크레틴 기반 약제들이 적절히 공급되고 처방될 수 있는 방안들을 심도 있게 논의하고자 한다.

CS06-L1 Jang Won SonThe Catholic University of Korea, Korea: GLP-1RAs in Korea: clinical use, real-world trends, and emerging therapeutics
(현재 사용되는 제제들의 현황: 우리나라에서 GLP1RA의 역사와 현재 사용 실태, 새로 개발된 약제들의 효과)

CS06-L2 Sun Ok SongNational Health Insurance Service Ilsan Hospital, Korea: Use of newly released incretin-based therapies under current Korean clinical circumstances: optimizing efficacy and safety in real-world practice
(국내 승인된 최신 인크레틴 제제의 효과적 적용: 허가 현황 및 국내 진료 지침 적용, 실제 진료에서의 안전성 효율성을 고려한 치료)

Panel discussion

CS06-P1
Sang Soo KimPusan National University, Korea
CS06-P2
Jae Hyuk LeeMyongji Hospital, Korea
CS06-P3
Kookhee KimHealth Insurance Review & Assessment Service (HIRA), Korea
CS06-P4
Jinhan LeeDongailbo, Korea

Diabetes in Asia 2025 session Diabetes in Asia 2025 Chair(s): So Hun Kim, Sof Andrikopoulos
Friday 26 September, 16:30-17:50
Room 5
(Art Hall, 4F)

Building on the success of last year’s session, the International Liaison Committee presents “Diabetes in Asia 2025” at ICDM 2025. This session will once again spotlight the latest epidemiological trends and real-world challenges in diabetes management from Korea (including the Korean Diabetes Fact Sheet) and our fellow countries-Indonesia, India, Fiji, and Kazakhstan (representing Central Asia). Presentations will emphasize the diversity of diabetes across these nations and highlight unique patterns and experiences from each country. By sharing up-to-date data and perspectives, the session aims to foster cross-national learning and strengthen collaborative efforts for better diabetes care in our region.

CS07-L1 Se Eun ParkSungkyunkwan University, Korea: Diabetes fact sheet in Korea

CS07-L2 Dicky Levenus TahaparyUniversity of Indonesia, Indonesia: Diabetes in Indonesia: increasing burden and innovative strategies

CS07-L3 Arman DuisenbayevPF Central Asian Diabetology Forum, Republic of Kazakhstan: Diabetes in Central Asia

CS07-L4 Banshi SabooDiabetes Care & Hormone Clinic, India: Diabetes in India

CS07-L5 Jemesa TudravuMinistry of Health and Medical Services, Fiji: Diabetes in Fiji and Pacific Island

Diabetes and metabolism journal session The best paper of the year 2025 Chair(s): Kyung Mook Choi, Hyuk-Sang Kwon
Saturday 27 September, 11:00~12:20
Room 2
(Vista 3, B2F)

The Diabetes and Metabolism Journal (DMJ) is the official journal of the Korean Diabetes Association, with an impact factor of 8.5 in 2024. This session presents research from six outstanding papers published in 2024, carefully selected by the Publication Committee through a rigorous review process. We appreciate your continued support for DMJ's growth and development.

CS04-L1 Ye Seul YangSeoul National University, Korea: Real-world treatment patterns according to clinical practice guidelines in patients with type 2 diabetes mellitus and established cardiovascular disease in Korea: multicenter, retrospective, observational study

CS04-L2 Ji Yoon KimSungkyunkwan University, Korea: Recent glycemia is a major determinant of β-cell function in type 2 diabetes mellitus

CS04-L3 Yoseob LeeYonsei University, Department of Biomedical Sciences, Korea: DGAT2 plays a crucial role to control ESRRAPROX1 transcriptional network to maintain hepatic mitochondrial sustainability

CS04-L4 Zhe WangShandong Provincial Hospital, China: Single-cell landscape and a macrophage subset enhancing brown adipocyte function in diabetes

CS04-L5 Mihye SeoSoonchunhyang University, Korea: 2023 diabetic kidney disease fact sheet in Korea

CS04-L6 Teruki MiyakeEhime University, Japan: Glycemic control is associated with histological findings of metabolic dysfunction-associated steatotic liver disease

Committee of Publication session TBD Chair(s): Hyuk-Sang Kwon, In-Kyung Jeong
Saturday 27 September, 13:10~14:30
Room 2
(Vista 3, B2F)

The purpose of this session is to discuss the current position and role of DMJ, the official journal of the Korean Diabetes Association, and to explore ways to develop it into a global journal beyond the Asia-Pacific region.

CS08-L1 David D'AlessioDuke University, USA: Scientific publishing: lessons learned over 4 years as editor of diabetes

CS08-L2 Won KimSeoul National University, Korea: How was clinical and molecular hepatology(CMH) able to grow into a high-impact journal?

CS08-L3 Jae Hyun BaeSeoul National University, Korea: Publishing DMJ: reflections and challenges on the path to global recognition

CS08-P1 Dae Jung KimAjou University, Korea: Panel discussion

CS08-P2 Jae-Han JeonKyungpook National University, Korea: Panel discussion

CS08-P3 TBDTBD: Panel discussion

Committee of international liaison session Overcoming the twin epidemics: T2DM and Obesity Chair(s): So Hun Kim, Daisuke Yabe
Saturday 27 September, 13:10~14:30
Room 4
(Walker hall 2, 1F)

"Overcoming the Twin Epidemics: T2DM and Obesity" will address the rising prevalence and shared pathophysiology of type 2 diabetes and obesity in Asia. This session brings together leading experts from Japan, Korea, Malaysia, and Taiwan to discuss cutting-edge therapeutic approaches, including incretin-based therapies and bariatric surgery. Emphasis will be placed on multidisciplinary and region-specific strategies to combat these interconnected epidemics, with opportunities for interactive discussion among participants.

CS09-L1 Daisuke YabeKyoto University, Japan: Incretin based therapies: is it the ultimate savior for diabetes and obesity treatment?

CS09-L2 Sang-Yong SonAjou University, Department of Surgery, Korea: From scale to success: the life-changing impact of bariatric surgery

CS09-L3 Lee-Ling LimUniversiti Malaya, Malaysia: Epidemiology and management of obesity in diabetes – Malaysia

CS09-L4 Wayne Huey-Herng SheuNational Health Research Institutes, Taiwan: Epidemiology and management of obesity in diabetes – Taiwan

Panel discussion

CS09-P1
Da Hea SeoInha University, Korea
CS09-P2
Hae Jin KimAjou University, Korea
CS09-P3
Eun-Jung RheeSungkyunkwan University, Korea
CS09-P4
Umaira AzizEmirates Health Services, UAE

Committee of public relation session (K&E) Specialized DFS insights on GDM and obesity and expanded perspectives on severe diabetes Chair(s): Sungrae Kim, Sunghee Choi
Saturday 27 September, 13:10~14:30
Room 5
(Art Hall, 4F)

This session consists of two parts. The first part will feature two lectures presenting diabetes fact sheets on gestational diabetes mellitus and obesity in type 2 diabetes, based on representative national statistics from Korea. The second part will focus on severe diabetes in Korea, followed by a discussion led by invited experts who will address a range of related issues. Overall, the session aims to provide a comprehensive understanding and meaningful insights into the current landscape of diabetes in Korea.

CS10-L1 Joon Ho MoonSeoul National University, Korea: DIP (diabetes in pregnancy) fact sheet in Korea

CS10-L2 Seung-Hwan LeeThe Catholic University of Korea, Korea: Obese diabetes fact sheet in Korea

CS10-L3 Young Min ChoSeoul National University, Korea: Classification of severe diabetes mellitus: a staging and grading framework based on pathophysiology and complications

구분		사전등록 (~2025년 8월 20일까지)		현장등록 (2025년 9월 25일 ~ 27일)
구분		KDA회원	비회원	KDA회원	비회원
25~27일 등록	전문의(개원의, 교수, 봉직의, 전임의 포함)	KRW 280,000	KRW 350,000	KRW 370,000	KRW 450,000
25~27일 등록	전공의, 간호사, 영양사, 사회복지사, 약사, 연구원, 운동처방사, 관련분야 교수 및 기타 (군의관 및 공중보건의 포함)	KRW 180,000	KRW 230,000	KRW 250,000	KRW 270,000
One-day 등록	전문의(개원의, 교수, 봉직의, 전임의 포함)	KRW 170,000	KRW 210,000	KRW 220,000	KRW 270,000
One-day 등록	전공의, 간호사, 영양사, 사회복지사, 약사, 연구원, 운동처방사, 관련분야 교수 및 기타 (군의관 및 공중보건의 포함)	KRW 110,000	KRW 140,000	KRW 150,000	KRW 160,000
저녁 식사	전체	KRW 55,000

Program details

평점안내 (For Korean)